- Epigenetic Modification Mechanisms Involved in Inflammation and Fibrosis in Renal Pathology
Jose Luis Morgado-Pascual et al, 2018, Mediators of Inflammation CrossRef - Decreased Poly(ADP-Ribose) Polymerase 1 Expression Attenuates Glucose Oxidase-Induced Damage in Rat Cochlear Marginal Strial Cells
Yuanyuan Zhang et al, 2016, Molecular Neurobiology CrossRef - Molecular mechanisms underlying the clinical efficacy of panobinostat involve Stochasticity of epigenetic signaling, sensitization to anticancer drugs, and induction of cellular cell death related to cellular stresses
Nasreddine El Omari et al, 2023, Biomedicine & Pharmacotherapy CrossRef - Overcoming Chemotherapy Resistance in Metastatic Cancer: A Comprehensive Review
Maryam Eslami et al, 2024, Biomedicines CrossRef - The HIV protease inhibitor, ritonavir, dysregulates human platelet function in vitro
Shannon G. Loelius et al, 2018, Thrombosis Research CrossRef - Drug repurposing in cancer
Linda Sleire et al, 2017, Pharmacological Research CrossRef - Epigenome Aberrations: Emerging Driving Factors of the Clear Cell Renal Cell Carcinoma
Ali Mehdi et al, 2017, International Journal of Molecular Sciences CrossRef - Drug rechanneling: A novel paradigm for cancer treatment
Itishree Kaushik et al, 2021, Seminars in Cancer Biology CrossRef - Sequential pathogenesis of metastatic VHL mutant clear cell renal cell carcinoma: putting it together with a translational perspective
N. Shenoy et al, 2016, Annals of Oncology CrossRef